Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation

With post-transplantation cyclophosphamide (PTCy) as graft-versus-host disease (GVHD) prophylaxis, nonmyeloablative HLA-haploidentical (NMA haplo) and HLA-matched blood or marrow transplantation (BMT) have comparable outcomes. Early discontinuation of immunosuppression may reduce the risk of relapse...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Biol Blood Marrow Transplant
Päätekijät: Kasamon, Yvette L., Fuchs, Ephraim J., Zahurak, Marianna, Rosner, Gary L., Symons, Heather J., Gladstone, Douglas E., Huff, Carol Ann, Swinnen, Lode J., Brodsky, Robert A., Matsui, William H., Borrello, Ivan, Shanbhag, Satish, Cooke, Kenneth R., Ambinder, Richard F., Luznik, Leo, Bolaños-Meade, Javier, Jones, Richard J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5977987/
https://ncbi.nlm.nih.gov/pubmed/29353109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.01.011
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia